Takeda has elected to nix all manufacturing of its Natpara injection for hypoparathyroidism in the U.S. and abroad by the end of 2024. After an indefinite commercial delay on its Shire-acquired ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award.This prestigious global award ...

From the commercial standpoint, Takeda and Protagonist project Rusfertide to generate up to $1-2 billion in the U.S. at peak sales (see image below). Given the current partnership agreement, ...

Takeda Pharmaceuticals struck a deal with AcuraStem to purchase its amyotrophic lateral sclerosis (ALS) treatment program on Monday. Per terms of the transaction, the Japanese pharma giant will ...

Under the terms of the Takeda agreement, Protagonist is responsible for the phase 3 programme and regulatory filing in the US, while the Japanese drugmaker takes on all regulatory and commercial ...

Takeda has added another piece to the patchwork of bispecific antibody capabilities it has sewn together over the past 18 months, tapping F-star Therapeutics to support an immuno-oncology program.

Takeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins market. In recent months, the company's share ...

Takeda delivered US$203 million in net sales of FRUZAQLA ® in the nine months ended September 2024. This US$20 million payment will be the first ever commercial milestone payment received by ...

They chose Takeda because they believe the Japanese pharma giant has the development and commercial infrastructure to maximize the asset’s value by pursuing broader opportunities than Keros ...

Under the agreement, Takeda will pay Hutchmed $400 million up front and up to $730 million in additional potential payments relating to regulatory, development, and commercial sales milestones, as ...

Takeda's new building at 585 Kendall has reached a construction milestone. Together with Suffolk Construction, Takeda, and Global Arts Live, BioMed Realty hosted a topping-off ceremony on Jan. 21.